422 related articles for article (PubMed ID: 11896503)
1. Is aldosterone the missing link in refractory hypertension?: aldosterone-to-renin ratio as a marker of inappropriate aldosterone activity.
Lim PO; Jung RT; MacDonald TM
J Hum Hypertens; 2002 Mar; 16(3):153-8. PubMed ID: 11896503
[TBL] [Abstract][Full Text] [Related]
2. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
[TBL] [Abstract][Full Text] [Related]
4. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in diagnosis and treatment of primary aldosteronism.
Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
[TBL] [Abstract][Full Text] [Related]
6. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
7. Primary aldosteronism, a common entity? the myth persists.
Padfield PL
J Hum Hypertens; 2002 Mar; 16(3):159-62. PubMed ID: 11896504
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism?
Tomaschitz A; Pilz S
Horm Metab Res; 2010 Jun; 42(6):382-91. PubMed ID: 20225167
[TBL] [Abstract][Full Text] [Related]
9. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
Mahmud A; Mahgoub M; Hall M; Feely J
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
[TBL] [Abstract][Full Text] [Related]
10. [Screening tests and diagnostic examinations of hypertensives for primary aldosteronism].
Omura M; Nishikawa T
Rinsho Byori; 2006 Nov; 54(11):1157-63. PubMed ID: 17240838
[TBL] [Abstract][Full Text] [Related]
11. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
12. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
[TBL] [Abstract][Full Text] [Related]
13. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
[TBL] [Abstract][Full Text] [Related]
14. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
[TBL] [Abstract][Full Text] [Related]
15. Optimal use and interpretation of the aldosterone renin ratio to detect aldosterone excess in hypertension.
Doi SA; Abalkhail S; Al-Qudhaiby MM; Al-Humood K; Hafez MF; Al-Shoumer KA
J Hum Hypertens; 2006 Jul; 20(7):482-9. PubMed ID: 16617310
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
[TBL] [Abstract][Full Text] [Related]
17. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of a raised aldosterone-renin ratio (ARR) among new referrals to a hypertension clinic.
Williams D; Croal B; Furnace J; Ross S; Witte K; Webster M; Critchen W; Webster J
Blood Press; 2006; 15(3):164-8. PubMed ID: 16864158
[TBL] [Abstract][Full Text] [Related]
19. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
Hood SJ; Taylor KP; Ashby MJ; Brown MJ
Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
[TBL] [Abstract][Full Text] [Related]
20. [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].
Zhang HL; Liu ZJ; Shao JM; Yan JT; Wang DW
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):873-6. PubMed ID: 17217709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
